USPTO serial 79168175
AUTOLUS
Reviewed by CopyMark Law Group
Reg. 4920212Status 404
- Filing date
- Status date
- Registration date
- Mar 22, 2016
- Examiner
- THOMAS, JULIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AUTOLUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark Harrison
Mark Harrison Venable LLPP.O. Box 34385Washington, DC 20043-9998UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical and veterinary preparations, namely, engineered T-cells for therapeutic purposes; preparations for cell therapy, namely, engineered T-cells; preparations for gene therapy, namely, engineered T-cells; biological preparations for cancer therapies; medical preparations, namely, chimeric antigen receptors (CAR) and therapeutic preparations thereof, namely, viral vectors expressing CAR genes; therapeutic antibodies for use as immunotherapeutic agents; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, scientific research; industrial analysis and research services in the field of T-cells and chimeric antigen receptors; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services | SECTION 71 - CANCELLED | — |
| 044 | Medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Autolus Limited C/O Syncona Partners
- Other trademarks owned by Autolus Limited C/O Syncona Partners
- Other trademarks owned by Autolus Limited
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AUTOLUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Feb 12, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 15, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 15, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 9, 2025 | Further Decision Processed by IB | — | |
| Mar 20, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 20, 2025 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Mar 20, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jun 7, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 7, 2022 | C71T | CANCELLED SECTION 71 | — |
| Oct 3, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 22, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 15, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 23, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 23, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 22, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 8, 2016 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Apr 1, 2016 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Mar 22, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 5, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 5, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 16, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 16, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 16, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 28, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 23, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 23, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 23, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 22, 2015 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 6, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 6, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 6, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 5, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 6, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 2, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |